Wehling M - Search Results

1

Inhibition of platelet aggregation after intake of acetylsalicylic acid detected by a platelet function analyzer (PFA-100).

Feuring M, Haseroth K, Janson CP, Falkenstein E, Schmidt BM, Wehling M. Feuring M, et al. Among authors: wehling m. Int J Clin Pharmacol Ther. 1999 Dec;37(12):584-8. Int J Clin Pharmacol Ther. 1999. PMID: 10599950 Clinical Trial.

2

Monitoring acetylsalicylic acid effects with the platelet function analyzer PFA-100.

Feuring M, Schultz A, Losel R, Wehling M. Feuring M, et al. Among authors: wehling m. Semin Thromb Hemost. 2005;31(4):411-5. doi: 10.1055/s-2005-916675. Semin Thromb Hemost. 2005. PMID: 16149018

3

Acute effects of a single oral dose of carvedilol on cardiac sympathovagal balance in man.

Haseroth K, Löffler P, Janson CP, Kropff S, Schmidt BM, Feuring M, Christ M, Wehling M. Haseroth K, et al. Among authors: wehling m. Int J Clin Pharmacol Ther. 2001 Jul;39(7):315-21. doi: 10.5414/cpp39315. Int J Clin Pharmacol Ther. 2001. PMID: 11471776 Clinical Trial.

4

Circadian variation of platelet function measured with the PFA-100.

Feuring M, Wehling M, Ruf A, Schultz A. Feuring M, et al. Among authors: wehling m. Platelets. 2009 Nov;20(7):466-70. doi: 10.3109/09537100903226034. Platelets. 2009. PMID: 19852684 Free article.

5

The PFA-100R cannot detect blood group-dependent inhibition of platelet function by eptifibatide or abciximab at therapeutic plasma concentrations.

Feuring M, Ruf A, Schultz A, Wehling M. Feuring M, et al. Among authors: wehling m. Platelets. 2010;21(3):176-82. doi: 10.3109/09537100903518260. Platelets. 2010. PMID: 20121459 Free article.

6

Coagulation status in patients with coronary artery disease taking 100 mg aspirin and healthy volunteers using PFA-100® and ROTEM®.

Feuring M, Wehling M, Ruf A, Burkhardt H, Schultz A. Feuring M, et al. Among authors: wehling m. Int J Clin Pharmacol Ther. 2011 May;49(5):328-35. doi: 10.5414/cp201418. Int J Clin Pharmacol Ther. 2011. PMID: 21543036

7

Lepirudin dose-dependently increases thrombelastography parameters at therapeutic plasma concentrations as measured with ROTEM® - a pilot study.

Feuring M, Wehling M, Schultz A. Feuring M, et al. Among authors: wehling m. Int J Clin Pharmacol Ther. 2011 Oct;49(10):626-8. doi: 10.5414/cp201542. Int J Clin Pharmacol Ther. 2011. PMID: 21961488

8

[Use of thrombocyte aggregation inhibitors in cardiology].

Schmidt BM, Wehling M. Schmidt BM, et al. Among authors: wehling m. Internist (Berl). 1997 Dec;38(12):1242-5. doi: 10.1007/s001080050135. Internist (Berl). 1997. PMID: 9465333 Review. German. No abstract available.

9

Dalteparin dose-dependently increases ROTEM(®) thrombelastography parameters only at supratherapeutic anti-factor Xa levels: an in vitro study.

Feuring M, Wehling M, Schultz A. Feuring M, et al. Among authors: wehling m. Clin Exp Pharmacol Physiol. 2011 Nov;38(11):783-6. doi: 10.1111/j.1440-1681.2011.05593.x. Clin Exp Pharmacol Physiol. 2011. PMID: 21883380

10

Rapid cardiovascular action of aldosterone in man.

Wehling M, Spes CH, Win N, Janson CP, Schmidt BM, Theisen K, Christ M. Wehling M, et al. J Clin Endocrinol Metab. 1998 Oct;83(10):3517-22. doi: 10.1210/jcem.83.10.5203. J Clin Endocrinol Metab. 1998. PMID: 9768657 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

387 results

Search Page

Filters